Preoperative Fibrinogen-to-Albumin Ratio as Potential Predictor of Bladder Cancer: A Monocentric Retrospective Study
Authors:
- Biagio BaroneBiagio Barone
- Luigi NapolitanoLNLuigi Napolitano
- Pasquale RecciaPRPasquale Reccia
- Luigi De LucaLLLuigi De Luca
- Simone MorraSimone Morra
- Carmine TurcoCTCarmine Turco
- Alberto MelchionnaAMAlberto Melchionna
- Vincenzo Francesco CaputoVCVincenzo Francesco Caputo
- Luigi CirilloLCLuigi Cirillo
- Giovanni Maria FuscoGFGiovanni Maria Fusco
- Francesco MastrangeloFMFrancesco Mastrangelo
- Francesco Paolo CalaceFCFrancesco Paolo Calace
Open Access
Abstract
Background and objective: Fibrinogen and albumin are two proteins widely used, singularly and in combination, in cancer patients as biomarkers of nutritional status, inflammation and disease prognosis. The aim of our study was to investigate the preoperative fibrinogen-to-albumin ratio (FAR) as a preoperative predictor of malignancy as well as advanced grade in patients with bladder cancer. Materials and Methods: A retrospective analysis of patients who underwent TURBT at our institution between 2017 and 2021 was conducted. FAR was obtained from preoperative venous blood samples performed within 30 days from scheduled surgery and was analyzed in relation to histopathological reports, as was the presence of malignancy. Statistical analysis was performed using a Kruskal–Wallis Test, and univariate and multivariate logistic regression analysis, assuming p < 0.05 to be statistically significant. Results: A total of 510 patients were included in the study (81% male, 19% female), with a mean age of 71.66 ± 11.64 years. The mean FAR was significantly higher in patients with low-grade and high-grade bladder cancer, with values of 80.71 ± 23.15 and 84.93 ± 29.96, respectively, compared to patients without cancer (75.50 ± 24.81) (p = 0.006). Univariate regression analysis reported FAR to be irrelevant when considered as a continuous variable (OR = 1.013, 95% CI = 1.004–1.022; p = 0.004), while when considered as a categorical variable, utilizing a cut-off set at 76, OR was 2.062 (95% CI = 1.378–3.084; p < 0.0001). Nevertheless, the data were not confirmed in the multivariate analysis. Conclusions: Elevated preoperative FAR is a potential predictor of malignancy as well as advanced grade in patients with bladder cancer. Further data are required to suggest a promising role of the fibrinogen-to-albumin ratio as a diagnostic biomarker for bladder tumors.Keywords
This publication has 40 references indexed in Scilit:
- Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosisJournal of Critical Care, 2016
- Different patterns in the prognostic value of age for bladder cancer-specific survival depending on tumor stages.2015
- Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinomaMedical Oncology, 2014
- Unraveling the mysteries of serum albumin—more than just a serum proteinFrontiers in Physiology, 2014
- Epidemiology and Risk Factors of Urothelial Bladder CancerEuropean Urology, 2013
- Urothelial CarcinomaAdvances in Urology, 2012
- Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literatureNutrition Journal, 2010
- Prognostic significance of preoperative plasma fibrinogen in endometrial cancerGynecologic Oncology, 2010
- Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathwayJournal of Thrombosis and Haemostasis, 2004
- Inflammation and cancer: back to Virchow?The Lancet, 2001